Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Adicionar filtros








Intervalo de ano
1.
Braz. j. med. biol. res ; 32(12): 1561-4, Dec. 1999. tab
Artigo em Inglês | LILACS | ID: lil-249385

RESUMO

The aim of the present study was to evaluate the effect of antidopaminergic agents on the somatotrophs in the presence of hyperprolactinemia. Adult male Wistar rats were divided into 6 groups: a control group and five groups chronically treated (60 days) with haloperidol, fluphenazine, sulpiride, metoclopramide or estrogen. Somatotrophs and lactotrophs were identified by immunohistochemistry and the data are reported as percent of total anterior pituitary cells counted. The drugs significantly increased the percentage of lactotrophs: control (mean + or - SD) 21.3 + or - 4.4, haloperidol 27.8 + or - 2.2, fluphenazine 34.5 + or - 3.6, sulpiride 32.7 + or - 3.5, metoclopramide 33.4 + or - 5.5 and estrogen 42.4 + or - 2.8. A significant reduction in somatotrophs was observed in animals treated with haloperidol (23.1 + or - 3.0), fluphenazine (22.1 + or - 1.1) and metoclopramide (24.2 + or - 3.0) compared to control (27.3 + or - 3.8), whereas no difference was observed in the groups treated with sulpiride (25.0 + or - 2.2) and estrogen (27.1 + or - 2.8). In the groups in which a reduction occurred, this may have simply been due to dilution, secondary to lactotroph hyperplasia. In view of the duplication of the percentage of prolactin-secreting cells, when estrogen was applied, the absence of a reduction in the percent of somatotrophs suggests a replication effect on this cell population. These data provide additional information about the direct or indirect effect of drugs which, in addition to interfering with the dopaminergic system, may act on other pituitary cells as well as on the lactotrophs.


Assuntos
Animais , Masculino , Ratos , Antagonistas de Dopamina/farmacologia , Estrogênios/farmacologia , Hormônio do Crescimento/efeitos dos fármacos , Hiperprolactinemia/metabolismo , Prolactina/efeitos dos fármacos , Flufenazina/farmacologia , Hormônio do Crescimento/análise , Haloperidol/farmacologia , Metoclopramida/farmacologia , Prolactina/análise , Ratos Wistar , Sulpirida/farmacologia
2.
Rev. ABP-APAL ; 15(1): 1-5, jan.-mar. 1993. tab, graf
Artigo em Português | LILACS | ID: lil-178148

RESUMO

Este trabalho apresenta a an lise das consultas realizadas a um serviço de informaçöes sobre substâncias psicoativas, em 42 meses de funcionamento. As 1.284 consultas foram feitas através de uma linha telef"nica, havendo contato direto com um plantonista, com manutençäo do anonimato, caso houvesse interesse do usu rio. Constatou-se que, apesar de ampla variaçäo no número de consultas por período, dependendo da divulgaçäo da existência do serviço, a média é de 1,5 consultas ao dia. Näo h preferência entre os sexos e o uso é näo profissional na maioria das perguntas. Questöes sobre drogas de abuso (inalantes e maconha) säo mais frequentes, havendo interesse na obtençäo de mais informaçöes sobre medicamentos prescritos (benzodiazepínicos e antidepressivos), tanto de açäo central como de outros tipos (drogas cardiovasculares e antimicrobianos). É pequeno o número de perguntas sobre cafeína, nicotina e alucinógenos


Assuntos
Serviços de Informação , Drogas Ilícitas , Centros de Tratamento de Abuso de Substâncias
3.
Braz. j. med. biol. res ; 25(3): 281-7, 1992. tab
Artigo em Inglês | LILACS | ID: lil-109029

RESUMO

It has been reported that sodium valproate induces a morphine-like withdrawal syndrome in rats. The effects of acute or chronic treatment with sodium valproate on rat behavior was studied in the open-field test. Acute sodium valproate (320 mg/kg, intraperitoneally) decreases the freuqncy of, and the time spent in grooming even when not modifying locomotion, rearing or defecation (N=15), either 15 or 60 min after an acute treatment. This effect was not modified (n+10) by concomitant administration of morphine (2 mg/kg) or naloxone (1 mg/kg). Interruption of prolonged (30 days) valproate treatment with increasing doses of 40 to 320 mg/kg, by gavage, twice daily (N=10) did not modify raty behavior in the open-field, from the first to the fourtheenth day of th test. We conclude that the decreased novely-induced grooming does not depend on the opioid system and may be related to anti-anxiety effect of valproate


Assuntos
Ratos , Comportamento Animal , Ácido gama-Aminobutírico , Morfina/administração & dosagem , Síndrome , Ácido Valproico/efeitos adversos , Ácido Valproico/terapia , Ansiolíticos
4.
Braz. j. med. biol. res ; 22(2): 213-24, 1989. ilus, tab
Artigo em Inglês | LILACS | ID: lil-105578

RESUMO

1. The effects of ß-phenylethylamine (PEA) alone and in association with caroxazone, a potent inhibitor of monoamine oxidase B (MAO B), on the activity and long-term memory in the wheel-shaped activity monitor and on fixed-interval two-way avoidance acquisition were studied in rats. In a separate study, we determined the effects of PEA and of d-amphetamine on the variable-internal two-way avoidance acquisition. 2. The action of PEA was markedly different from that of aplhetamine in several aspects. The stimulating effects of PEA in the wheel-shaped activity monitor were of a more subtle nature than those of amphetamine and in the variable-interval two-way avoidance acquisition PEA had no effect, while amphetamine improved performance. 3. PEA did not induce an increase in path-choice stereotypy, but caroxazone did. The absence of any caroxazone-session interaction effects on the path interation frequency suggested that there were no long-term memory effects. 4. In the fixed-interval two-way avoidance acquisition experiments, PEA increased the avoidance responses of tats while caroxazone had no effect. The association of the two drugs did not potenciate either


Assuntos
Animais , Feminino , Ratos , Aprendizagem da Esquiva/efeitos dos fármacos , Dextroanfetamina/farmacologia , Oxazinas/farmacologia , Fenetilaminas/farmacologia , Interações Medicamentosas , Comportamento Exploratório/efeitos dos fármacos , Memória/efeitos dos fármacos , Atividade Motora/efeitos dos fármacos , Ratos Endogâmicos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA